Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Amgen Inc

Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA, United States

  1. PrincipalsDavid M ReeseEVP & Chief Technology OfficerMatthew C. BuschVP, Finance & CAOPeter H. GriffithEVP & CFOand 11 more
  2. CompanyAmgen IncThousand Oaks, CA, United States
  3. Phone line+1 (805) 447-1000General business
Request a quote

Amgen Inc is an SEC-registered Nasdaq-listed company (ticker AMGN) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 14

Chief executive

Robert A BradwayChairman, CEO and President

Chair & board

Charles M HolleyDirector (Board)
Michael V DrakeDirector (Board)
Omar IshrakDirector (Board)

Finance

Operations

Esteban SantosEVP, Operations

Sales & commercial

Murdo GordonEVP, Global Commercial Ops
Rachna KhoslaSVP, Business Development

Technology & engineering

David M ReeseEVP & Chief Technology Officer
James E. BradnerEVP, Research and Development

Legal

Jonathan P GrahamEVP & Gen. Counsel & Sec.
Everyone else on file (3)
Matthew C. BuschVP, Finance & CAO
Derek MillerSVP, Human Resources

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. David M Reese — EVP & Chief Technology Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Robert A Bradway — Chairman, CEO and President

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Matthew C. Busch — VP, Finance & CAO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers